Tribune Therapeutics is a preclinical biopharmaceutical company building a promising pipeline of novel medicines to treat patients with a wide range of fibrotic diseases. Tribune Therapeutics was founded by Dr. Kaasbøll, Professor Attramadal and Mr. Vo Beiske together with HealthCap and Novo Seeds in 2020. Tribune Therapeutics has in-licensed an asset from Inven2, one of the largest technology transfer offices in the Nordic r...
Tribune Therapeutics is a preclinical biopharmaceutical company building a promising pipeline of novel medicines to treat patients with a wide range of fibrotic diseases. Tribune Therapeutics was founded by Dr. Kaasbøll, Professor Attramadal and Mr. Vo Beiske together with HealthCap and Novo Seeds in 2020. Tribune Therapeutics has in-licensed an asset from Inven2, one of the largest technology transfer offices in the Nordic region.Tribune Therapeutics is a preclinical biopharmaceutical company building a promising pipeline of novel medicines to treat patients with a wide range of fibrotic diseases.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.